TRAVERT 10% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Travert 10% In Plastic Container patents expire, and when can generic versions of Travert 10% In Plastic Container launch?
Travert 10% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVERT 10% IN PLASTIC CONTAINER is invert sugar. Additional details are available on the invert sugar profile page.
Summary for TRAVERT 10% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRAVERT 10% IN PLASTIC CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRAVERT 10% IN PLASTIC CONTAINER
US Patents and Regulatory Information for TRAVERT 10% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | TRAVERT 10% IN PLASTIC CONTAINER | invert sugar | INJECTABLE;INJECTION | 016717-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |